DBV TECHNOLOGIES S.A.

Profile

Company Names

DBV TECHNOLOGIES S.A.

Addresses

107 AVENUE DE LA REPUBLIQUE, CHATILLON, I0 92320

Phone Numbers

33(0)155427878

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

FRANCE

Total Amount Raised:

$306,900,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2025-04-07 
$306,900,000.00 
$306,900,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
VIRGINIE 
 
BOUCINHA 
EXECUTIVE OFFICER
DBV TECHNOLOGIES S.A.
MICHEL 
 
DE ROSEN 
DIRECTOR
DBV TECHNOLOGIES S.A.
MAILYS 
 
FERRERE 
DIRECTOR
SEQUANS COMMUNICATIONS   |  DBV TECHNOLOGIES S.A.
MICHAEL 
 
GOLLER 
DIRECTOR
DIADEXUS INC   |  DBV TECHNOLOGIES S.A.   |  TERREMOTO BIOSCIENCES, INC.
DANIELE 
 
GUYOT-CAPARROS 
DIRECTOR
DBV TECHNOLOGIES S.A.
PHARIS 
 
MOHIDEEN 
EXECUTIVE OFFICER
MILLENDO THERAPEUTICS, INC.   |  DBV TECHNOLOGIES S.A.
TIMOTHY 
E. 
MORRIS 
DIRECTOR
DBV TECHNOLOGIES S.A.
ADORA 
 
NDU 
DIRECTOR
DBV TECHNOLOGIES S.A.
JULIE 
 
O-NEILL 
DIRECTOR
HOOKIPA PHARMA INC.   |  DBV TECHNOLOGIES S.A.
RAVI 
MADDURI 
RAO 
DIRECTOR
DBV TECHNOLOGIES S.A.
DANIEL 
 
SOLAND 
DIRECTOR
DBV TECHNOLOGIES S.A.
DANIEL 
 
TASSE 
EXECUTIVE OFFICER, DIRECTOR
IKARIA HOLDINGS INC   |  BELLEROPHON THERAPEUTICS LLC   |  COMPOUND HOLDINGS I, LLC   |  BIOQ PHARMA INC   |  ALCRESTA, INC.   |  ALCRESTA THERAPEUTICS, INC.   |  BELLEROPHON THERAPEUTICS, INC.   |  DBV TECHNOLOGIES S.A.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-04-17
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-04-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LIFESCI CAPITAL LLC
168404
NONE
NONE
VAN LANSCHOT KEMPEN NV
NONE
NONE
NONE
VAN LANSCHOT KEMPEN (USA) INC.
38760